换一批
换一批Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
作者：
主题词
投药, 口服(Administration, Oral);秃发(Alopecia);蒽环类(Anthracyclines);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);便秘(Constipation);环磷酰胺(Cyclophosphamide);地塞米松(Dexamethasone);双盲法(Double-Blind Method);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);头痛(Headache);人类(Humans);注射, 静脉内(Injections, Intravenous);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);恶心(Nausea);肿瘤(Neoplasms);中性粒细胞减少(Neutropenia);昂丹司琼(Ondansetron);哌嗪类(Piperazines);哌啶类(Piperidines);治疗结果(Treatment Outcome);呕吐(Vomiting)
DOI
10.1200/JCO.2009.21.8511
PMID
19805683
发布时间
2013-11-21
- 浏览22
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
